Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds

Details for Australian Patent Application No. 2004255342 (hide)

Owner Novartis AG

Inventors Vedananda, Thalaththani Ralalage

Agent Davies Collison Cave

Pub. Number AU-B-2004255342

PCT Pub. Number WO2005/005421

Priority 60/485,870 08.07.03 US

Filing date 7 July 2004

Wipo publication date 20 January 2005

Acceptance publication date 20 November 2008

International Classifications

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2005/005421 Priority application(s): WO2005/005421

20 November 2008 Application Accepted

  Published as AU-B-2004255342

8 January 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 09 Dec 2008. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

14 May 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Dec 2008

14 May 2009 Standard Patent Sealed

3 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255344-Benzofuran derivatives and their use in the treatment of microbial infections

2004255340-Use of rapamycin and rapamycin derivatives for the treatment of bone loss